Subbroto Kumar Saha

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Venues

International journal of molecular sciences

Journal of personalized medicine

Journal of clinical medicine

Cancer gene therapy

Johns Hopkins Medicine

Konkuk University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins Medicine Jan 20 2020

United States

Post Doctoral Reseracher :: Gynecology And Obstetrics

Konkuk University Mar 01 2018 - Jan 17 2020

South Korea

Research Assistant Professor :: Stem Cell and Regenerative Biotechnology

Konkuk University Sep 04 2017 - Feb 28 2018

South Korea

Post Doctoral Research Fellow :: Stem Cell and Regenerative Biotechnology

Konkuk University Jan 01 2013 - Feb 28 2013

South Korea

Research Assistant :: Animal Biotechnology

Sejong University

South Korea

Research assistant :: Environmental Science

Islamic University

Bangladesh

Research assistant :: Biotechnology & Genetic Engineering

Education History

Konkuk University - Aug 22 2017

South Korea

PHD :: Animal Biotechnology

Islamic University

Bangladesh

MSC :: Biotechnology &Genetic Engineering

Islamic University

Bangladesh

BSC :: Biotechnology & Genetic Engineering

Publications

Polash Kumar Biswas, Sang Rok Park, Jongyub An, Kyung Min Lim, Ahmed Abdal Dayem, Kwonwoo Song, Hye Yeon Choi, Yujin Choi, Kyoung Sik Park, Hyun Jin Shin, Aram Kim, Minchan Gil, Subbroto Kumar Saha, Ssang-Goo Cho
The Orphan GPR50 Receptor Regulates the Aggressiveness of Breast Cancer Stem-like Cells via Targeting the NF-kB Signaling Pathway. International journal of molecular sciences 24 (3) (2023)
Polash Kumar Biswas, Sang Rok Park, Jongyub An, Kyung Min Lim, Ahmed Abdal Dayem, Kwonwoo Song, Hye Yeon Choi, Yujin Choi, Kyoung Sik Park, Hyun Jin Shin, Aram Kim, Minchan Gil, Subbroto Kumar Saha, Ssang-Goo Cho
The Orphan GPR50 Receptor Regulates the Aggressiveness of Breast Cancer Stem-like Cells via Targeting the NF-kB Signaling Pathway. International journal of molecular sciences 24 (3) (2023)
Polash Kumar Biswas, Sang Rok Park, Jongyub An, Kyung Min Lim, Ahmed Abdal Dayem, Kwonwoo Song, Hye Yeon Choi, Yujin Choi, Kyoung Sik Park, Hyun Jin Shin, Aram Kim, Minchan Gil, Subbroto Kumar Saha, Ssang-Goo Cho
The Orphan GPR50 Receptor Regulates the Aggressiveness of Breast Cancer Stem-like Cells via Targeting the NF-kB Signaling Pathway. International journal of molecular sciences 24 (3) (2023)
Tianyu Zhao, Moira McMahon, Kurt Reynolds, Subbroto Kumar Saha, Arjun Stokes, Chengji J Zhou
The role of Lrp6-mediated Wnt/β-catenin signaling in the development and intervention of spinal neural tube defects in mice. Disease models & mechanisms 15 (6) (2022)
Ran Gu, Shuwen Zhang, Subbroto Kumar Saha, Yu Ji, Kurt Reynolds, Moira McMahon, Bo Sun, Mohammad Islam, Paul A Trainor, YiPing Chen, Ying Xu, Yang Chai, Diana Burkart-Waco, Chengji J Zhou
Single-cell transcriptomic signatures and gene regulatory networks modulated by Wls in mammalian midline facial formation and clefts. Development (Cambridge, England) 149 (14) (2022)
Sheikh Tanzina Haque, Subbroto Kumar Saha, Md Enamul Haque, Nirupam Biswas
Nanotechnology-based therapeutic applications: in vitro and in vivo clinical studies for diabetic wound healing. Biomaterials science 9 (23) (2021)
Jaekwon Seok, Minchan Gil, Ahmed Abdal Dayem, Subbroto Kumar Saha, Ssang-Goo Cho
Multi-Omics Analysis of SOX4, SOX11, and SOX12 Expression and the Associated Pathways in Human Cancers. Journal of personalized medicine 11 (8) (2021)
Hee Sung Chae, Minchan Gil, Subbroto Kumar Saha, Hee Jeung Kwak, Hwan-Woo Park, Balachandar Vellingiri, Ssang-Goo Cho
Sestrin2 Expression Has Regulatory Properties and Prognostic Value in Lung Cancer. Journal of personalized medicine 10 (3) (2020)
Subbroto Kumar Saha, Tak-Il Jeon, Soo Bin Jang, Se Jong Kim, Kyung Min Lim, Yu Jin Choi, Hyeong Gon Kim, Aram Kim, Ssang-Goo Cho
Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis/Bladder Pain Syndrome with Hunner Lesion. Journal of clinical medicine 9 (6) (2020)
Hee Jeong Kwak, Minchan Gil, Hee Sung Chae, Jaekwon Seok, Nagasundarapandian Soundrarajan, Subbroto Kumar Saha, Aram Kim, Kyoung Sik Park, Chankyu Park, Ssang-Goo Cho
Expression of ATP/GTP Binding Protein 1 Has Prognostic Value for the Clinical Outcomes in Non-Small Cell Lung Carcinoma. Journal of personalized medicine 10 (4) (2020)
Subbroto Kumar Saha, Yingfu Yin, Hee Sung Chae, Ssang-Goo Cho
Opposing Regulation of Cancer Properties via KRT19-Mediated Differential Modulation of Wnt/β-Catenin/Notch Signaling in Breast and Colon Cancers. Cancers 11 (1) (2019)
Subbroto Kumar Saha, Kyung Eun Kim, S M Riazul Islam, Ssang-Goo Cho, Minchan Gil
Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers. Journal of clinical medicine 8 (4) (2019)
Subbroto Kumar Saha, S M Riazul Islam, M Abdullah-Al-Wadud, Saiful Islam, Farman Ali, Kyoung Sik Park
Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer. Journal of clinical medicine 8 (3) (2019)
Subbroto Kumar Saha, S M Riazul Islam, Kyung-Sup Kwak, Md Shahedur Rahman, Ssang-Goo Cho
PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis. Cancer gene therapy 27 (3-4) (2019)
Subbroto Kumar Saha, Yeojin Jeong, Sungha Cho, Ssang-Goo Cho
Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes. Scientific reports 8 (1) (2018)
Subbroto Kumar Saha, Kyeongseok Kim, Gwang-Mo Yang, Hye Yeon Choi, Ssang-Goo Cho
Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells. International journal of molecular sciences 19 (5) (2018)
Mohammed Kawser Hossain, Subbroto Kumar Saha, Ahmed Abdal Dayem, Jung-Hyun Kim, Kyeongseok Kim, Gwang-Mo Yang, Hye Yeon Choi, Ssang-Goo Cho
Bax Inhibitor-1 Acts as an Anti-Influenza Factor by Inhibiting ROS Mediated Cell Death and Augmenting Heme-Oxygenase 1 Expression in Influenza Virus Infected Cells. International journal of molecular sciences 19 (3) (2018)

Subbroto Kumar Saha.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Subbroto Kumar Saha